rs7984

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000539.3(RHO):​c.-26A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.216 in 1,613,362 control chromosomes in the GnomAD database, including 61,563 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 17743 hom., cov: 32)
Exomes 𝑓: 0.20 ( 43820 hom. )

Consequence

RHO
NM_000539.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.33

Publications

20 publications found
Variant links:
Genes affected
RHO (HGNC:10012): (rhodopsin) The protein encoded by this gene is found in rod cells in the back of the eye and is essential for vision in low-light conditions. The encoded protein binds to 11-cis retinal and is activated when light hits the retinal molecule. Defects in this gene are a cause of congenital stationary night blindness. [provided by RefSeq, Aug 2017]
RHO Gene-Disease associations (from GenCC):
  • congenital stationary night blindness autosomal dominant 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 4
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fundus albipunctatus
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 3-129528708-A-G is Benign according to our data. Variant chr3-129528708-A-G is described in ClinVar as [Benign]. Clinvar id is 256383.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.819 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RHONM_000539.3 linkc.-26A>G 5_prime_UTR_variant Exon 1 of 5 ENST00000296271.4 NP_000530.1 P08100

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RHOENST00000296271.4 linkc.-26A>G 5_prime_UTR_variant Exon 1 of 5 1 NM_000539.3 ENSP00000296271.3 P08100

Frequencies

GnomAD3 genomes
AF:
0.378
AC:
57383
AN:
151928
Hom.:
17682
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.826
Gnomad AMI
AF:
0.179
Gnomad AMR
AF:
0.342
Gnomad ASJ
AF:
0.286
Gnomad EAS
AF:
0.633
Gnomad SAS
AF:
0.383
Gnomad FIN
AF:
0.0702
Gnomad MID
AF:
0.287
Gnomad NFE
AF:
0.150
Gnomad OTH
AF:
0.344
GnomAD2 exomes
AF:
0.277
AC:
69244
AN:
250244
AF XY:
0.268
show subpopulations
Gnomad AFR exome
AF:
0.838
Gnomad AMR exome
AF:
0.277
Gnomad ASJ exome
AF:
0.276
Gnomad EAS exome
AF:
0.637
Gnomad FIN exome
AF:
0.0668
Gnomad NFE exome
AF:
0.153
Gnomad OTH exome
AF:
0.243
GnomAD4 exome
AF:
0.200
AC:
291721
AN:
1461316
Hom.:
43820
Cov.:
33
AF XY:
0.204
AC XY:
148025
AN XY:
726934
show subpopulations
African (AFR)
AF:
0.853
AC:
28533
AN:
33458
American (AMR)
AF:
0.281
AC:
12539
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.279
AC:
7290
AN:
26134
East Asian (EAS)
AF:
0.589
AC:
23357
AN:
39684
South Asian (SAS)
AF:
0.379
AC:
32696
AN:
86218
European-Finnish (FIN)
AF:
0.0703
AC:
3747
AN:
53304
Middle Eastern (MID)
AF:
0.301
AC:
1709
AN:
5676
European-Non Finnish (NFE)
AF:
0.150
AC:
166486
AN:
1111804
Other (OTH)
AF:
0.255
AC:
15364
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
11534
23068
34603
46137
57671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6604
13208
19812
26416
33020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.378
AC:
57507
AN:
152046
Hom.:
17743
Cov.:
32
AF XY:
0.378
AC XY:
28116
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.826
AC:
34264
AN:
41468
American (AMR)
AF:
0.342
AC:
5229
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.286
AC:
991
AN:
3468
East Asian (EAS)
AF:
0.632
AC:
3254
AN:
5146
South Asian (SAS)
AF:
0.383
AC:
1840
AN:
4810
European-Finnish (FIN)
AF:
0.0702
AC:
744
AN:
10600
Middle Eastern (MID)
AF:
0.274
AC:
80
AN:
292
European-Non Finnish (NFE)
AF:
0.150
AC:
10215
AN:
67976
Other (OTH)
AF:
0.345
AC:
727
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1152
2304
3457
4609
5761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.431
Hom.:
6541
Bravo
AF:
0.417
Asia WGS
AF:
0.505
AC:
1760
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pigmentary retinal dystrophy Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa 4 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital stationary night blindness autosomal dominant 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Retinitis pigmentosa Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.56
DANN
Benign
0.29
PhyloP100
-1.3
PromoterAI
0.0094
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7984; hg19: chr3-129247551; COSMIC: COSV56214291; API